欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/5154/001
药品名称
Nevirapine Sandoz
活性成分
nevirapine 200.0 mg
剂型
Tablet
上市许可持有人
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE The Netherlands From PT/0555/001
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Malta (MT)
Germany (DE)
Nevirapin Hetero 200 mg Tabletten
United Kingdom (Northern Ireland) (XI)
许可日期
2012/01/27
最近更新日期
2024/04/03
药物ATC编码
J05AG01 nevirapine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
patient_information_leaflet_for_variation_ib017g_validation
Date of last change:2023/07/03
Final SPC
|
summary_of_product_characteristics_for_variation_ib017g_vali
Date of last change:2023/07/03
PAR
|
200430 NL.H.5154.001.DC Nevirapine Sandoz PAR
Date of last change:2020/04/30
Final Product Information
|
DAY30AR_PTH0555001IB007
Date of last change:2015/03/05
Final Product Information
|
common_spc_clean
Date of last change:2015/03/05
Final Product Information
|
common-pl-clean
Date of last change:2015/03/05
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase